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Abstract 
Generalized anxiety and major depression disorders (MDD) are severe debilitating mood disor- 
ders whose etiology are not fully understood, but growing evidence indicates that microRNAs 
(miRNAs) might play a key role in their neuropathophysiological mechanisms. In the current 
study, we investigate the role of Lethal-7 (let-7d) miRNA, and its direct target dopamine D3 
receptor (D3R) gain-of-function, in the hippocampus, in preclinical models of anxiety and de- 
pression in mice. For this purpose, we have constructed a lentiviral vector carrying let-7d 
miRNA and its anxiolytic effect was investigated by employing the open-ﬁeld (OF) and the 
elevated plus maze (EPM) tests. The anti-depressant activity was evaluated using the tail sus- 
pension and the forced-swim tests (TST & FST). Our results show that let-7d overexpression 
signiﬁcantly improved the measures of anxiety in the OF and EPM tests. In addition, let-7d 
increased the mobility time in the TST and FST. Interestingly, gene expression interaction anal- 
ysis shows that the D3R mRNA negatively correlates with let-7d expression. In a different set 
of experiments, we used a tetracycline-inducible (tet-off) lentiviral vector to overexpress D3R 
to assess its gain-of-function in the hippocampus on anxiety- and depression-like behaviors. 
In line, we found that in the absence of doxycycline, D3R produced a signiﬁcant anxiogenic 
and depressant-like response. Most importantly, these effects were abrogated when mice were 
fed doxycycline in drinking water. Our results provide the ﬁrst evidence for an anxiolytic and 
Abbreviations: D3R, Dopamine D3 receptor; DOXY, Doxycycline; EPM, Elevated plus maze; FST, Forced swim test; Let-7, Lethal-7; LV, 
Lentiviral Vectors; miRNA, microRNA; OF, Open ﬁeld; TST, Tail suspension test; WTR, Water. 
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anti-depressant-like action of let-7d through a potential D3R target-mediated mechanism which 
might open new avenues for anxiolytic and anti-depressant therapies. 
© 2018 Elsevier B.V. and ECNP. All rights reserved. 
1. Introduction
According to the National Institute of Mental Health (NIMH), 
and the Anxiety and Depression Association of America 
(ADAA), anxiety disorders are the most common mental ill- 
ness in the US, affecting 40 million adults at the age 18 and 
older ( ADAA, 2014 ). Although these disorders lead to sig- 
niﬁcant suffering for the affected persons, their underly- 
ing causes are poorly understood. As such, identifying the 
molecular mechanisms common to anxiety and depression 
may prove crucial to successfully treating these illnesses. 
Previous investigations aimed at identifying the neuroadap- 
tations pertinent to this comorbidity have revealed a po- 
tential role for microRNAs (miRNAs) dysregulations in both 
anxiety and depression ( Giridharan et al., 2016 ). 
MiRNAs are small non-coding RNAs that regulate pro- 
tein synthesis post-transcriptionally by base-pairing to tar- 
get gene mRNAs. In mammals, miRNAs have been shown as 
one of the key regulators that control development of the 
CNS, including neurogenesis ( Liu and Zhao, 2009 ), neuronal 
proliferation ( Cheng et al., 2005 ), and synaptic plasticity 
( Kiebler and Bassell, 2006 ). Since the ﬁrst report identi- 
fying novel genes coding for small expressed RNAs ( Lagos- 
Quintana et al., 2001 ), it has been shown that because miR- 
NAs have a wide range of effects in the CNS, their implica- 
tion in the pathophysiology of mood has been recognized for 
some time ( Suarez-Gomez et al., 2011 ). In fact and in 2008, 
Uchida and co-workers reported that repeatedly restrained 
rats exhibited increased anxiety-related behavior that was 
associated to increased expression of miR-18a in the hy- 
pothalamic paraventricular nucleus (PVN) ( Uchida et al., 
2008 ). Also, molecular genetics and developmental studies 
have identiﬁed 21 genes in the chromosomal 8p region that 
are most likely to contribute to neuropsychiatric disorders 
such as depression, with at least seven nonprotein-coding 
miRNAs located in the same region ( Tabares-Seisdedos and 
Rubenstein, 2009 ). However, despite such a history of in- 
terest in this topic, many questions remain about the func- 
tions, brain targets, and mechanisms of miRNAs for their 
effects on mood disorders. 
Lethal-7 (let-7) is one of the most studied miRNA families. 
It is the most abundant among all miRNAs and is highly con- 
served between species. To date, the let-7 family consists of 
13 members (let-7a to let-7i, miR-98 and miR-202) located 
in 9 different loci on chromosomes 3, 9–12, 19, 21, 22 and X 
( Roush and Slack, 2008 ). Let-7d is abundant in the brain. In 
fact, using a microarray screening, Shu and colleagues found 
that let-7d was up-regulated in the hippocampus and the 
Marginal division (MrD) of the neostriatum ( Shu et al., 2013 ), 
suggesting that it may play an important role in modulating 
learning and memory ( Luo et al., 2015 ). Also, let-7d, which 
is increased in the prefrontal cortex of spontaneously hyper- 
tensive rats’ brain, negatively regulated galectin-3 which 
was associated with attention deﬁcit hyperactivity disorder 
development ( Wu et al., 2010 ). Furthermore, let-7d regu- 
lated neural stem cell proliferation and promoted prema- 
ture neuronal differentiation and migration ( Zhao et al., 
2013 ). In a previous study from our laboratory, we have 
shown a signiﬁcant downregulation of the D3R following let- 
7d overexpression in the nucleus accumbens, which was as- 
sociated with altered cocaine-conditioned place preference 
(CPP) ( Chandrasekar and Dreyer, 2011 ). This prompted us to 
investigate the potential role of let-7d and its direct tar- 
get D3R in the ethiology of anxiety and depression in adult 
mice. 
Dopamine, a major neurotransmitter in the CNS, is one 
of several neurotransmitters implicated in mood disorders. 
Dopamine exerts its effects through binding and activation 
of ﬁve subtypes of receptors (D1, D2, D3, D4 and D5 recep- 
tors), classiﬁed as D1-class receptors (D1 and D5) or D2-class 
receptors (D2, D3 and D4) ( Beaulieu et al., 2015 ). The D3R 
was cloned almost three decades ago, and evidence sug- 
gested that it is expressed in the limbic areas of the brain 
associated with emotion and psychiatric disorders ( Sokoloff
et al., 1990 ). In fact, dysregulation of the D3R has been 
linked to many psychiatric diseases including schizophrenia, 
addiction, anxiety, depression ( Leggio et al., 2016 ). Over- 
all, most of the studies linking the D3R to anxiety- and 
depression-like behaviors in rodents, involved systemic in- 
jection of D3R pharmacological agents or transgenic mice. 
Therefore, we have decided to employ a technique of viral- 
mediated gene transfer to manipulate D3R expression with 
a view of studying the effects of ectopic D3R mRNA levels 
on emotion-related behaviors. This technique had been ex- 
tensively used in our laboratory to manipulate this receptor 
in the rat brain ( Bahi et al., 2005; Bahi and Dreyer, 2014 ). 
For this purpose, in the present study we aimed to de- 
termine the effects of viral-mediated let-7d overexpression 
in the hippocampus in anxiety- and depression like pheno- 
types in mice, by means of a battery of behavioral tests. 
We also assessed the expression levels of let-7d and its di- 
rect target D3R in the hippocampus following let-7d overex- 
pression. Importantly, to conﬁrm a potential effect of hip- 
pocampal D3R-dependent behavioral tasks, consequences of 
lentiviral-mediated D3R manipulation of hippocampal area 
on anxiety and depression tasks were also examined. 
2. Experimental procedures
2.1. Animals
Adult male C57BL/6 mice weighing approximately 25 g were 
housed in standard Plexiglas observation cages. All mice 
were bred in the local central animal facility of the College 
of Medicine & Health Sciences and were kept under stan- 
dard laboratory conditions used to reduce mouse stress (12 h 
light/12 h dark cycle, lights off at 6pm, and approximately 
22 °C with 40–60% humidity). Bedding was autoclaved be- 
fore use and mice had free access to tap water and stan- 
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Fig. 1 Experimental timeline . The timelines show sequence 
and duration of experimental protocols of the effects of A) let- 
7d, and B) D3R overexpression on anxiety- and depression-like 
behaviors in adult mice. 
dard mouse chow diet obtained from the National Feed and 
Flour Production and Marketing Company LLC (Abu Dhabi, 
UAE). The experimental procedures were approved by the 
local Animal Research and Ethics Committee (Protocol No 
A17-12). 
2.2. Construction, production of the lentiviral 
vectors and stereotaxic injection 
The let-7d lentiviral vectors, driven by an RNA Pol 
III mouse U6 promoter, were prepared as described 
previously ( Chandrasekar and Dreyer, 2011 ). For the 
D3R-overexpressing lentiviral vectors, driven by a cy- 
tomegalovirus (CMV) promoter, the rat D3R was ampliﬁed 
from total brain cDNA using speciﬁc primers and ligated into 
pTK431 as described previously ( Bahi and Dreyer, 2014 ). 
To deliver the viruses into the hippocampus, we used 
stereotaxic injections as previously described for mice and 
rats ( Bahi et al., 2014b; Bahi and Dreyer, 2017 ). The com- 
plete dorsal and ventral hippocampus was targeted (includ- 
ing the CA ﬁelds, dentate gyrus, and subiculum) at four 
stereotaxic coordinates: 1st injection (AP - 1.7, ML + / −1.2, 
DV – 1.5); 2nd injection (AP - 2.3, ML + / −1.75, DV – 1.75); 
3rd injection (AP - 2.8, ML + / −3, DV – 3); 4th injection (AP 
−3.4, ML + /- 3, DV – 3.75) ( Devito et al., 2010; Franklin and 
Paxinos, 1996 ). In sham-operated controls, infusions were 
made in the same coordinates, except that instead it was 
the empty pTK431 cloning vector (Mock) that was injected 
through the Hamilton micro-syringe. For more details, see 
the Supplementary Material . 
In the ﬁrst experiment and after surgery, the mice of each 
group were single-housed and left to recover for 10 days as 
depicted in the experiment timeline ( Fig. 1 A). The mice had 
access to 0.075% saccharin dissolved in tap water ( w/v ). Two 
mice were removed from the study because they did not 
recover from the surgery. Therefore, for both Mock and let- 
7d groups n = 12 each. 
In the second experiment, after surgery the mice (Mock 
and D3R; n = 20 each) had access to 0.075% saccharin with 
or without 0.3 mg/ml doxycycline dissolved in tap water 
( w/v ) ( Fig. 1 B). This combination of viral-injection and 
doxycycline availability created four test groups ( n = 10 
each): Mock-WTR, D3R-WTR, Mock-DOXY, and D3R-DOXY. 
2.3. Behavioral analyses 
All the behavioral tests were conducted between 10 am and 
4 pm, and the mice were habituated to the room for at least 
1 h before testing. The general design of the study is de- 
picted in Fig. 1 A. 
2.3.1. Open ﬁeld (OF) test 
Spontaneous and exploratory locomotor activity and anxiety 
were assessed in an OF test, 10 days after the stereotaxic 
injections, as reported in our previous studies ( Bahi, 2017a; 
Bahi et al., 2016; Bahi et al., 2014a; Bahi et al., 2014c ). The 
anxiogenic-like phenotype was supported by decreased time 
spent in the center and by increased number of fecal boli 
left in the arena ( Bahi and Dreyer, 2017 ). After each session 
the arena was cleaned with a 70% pure ethanol solution to 
remove odor trails. For more details, see the Supplementary 
Material . 
2.3.2. Elevated-plus maze (EPM) test 
After the OF test, we assessed the effect of let-7d on 
anxiety-like behavior using the EPM test as we previously 
described ( Bahi, 2017a, 2017b ). For more details, see the 
Supplementary Material . 
2.3.3. Tail suspension test (TST) 
The TST is a common behavioral test to evaluate depressive- 
like behavior in animals and it was performed based as pre- 
viously described ( Bahi and Dreyer, 2012; Bahi et al., 2014c ). 
For more details, see the Supplementary Material . 
2.3.4. Forced-swim test (FST) 
The FST was performed as we described previously ( Bahi et 
al., 2014a; Bahi and Dreyer, 2012; Bahi et al., 2014c ). For 
more details, see the Supplementary Material . 
2.4. RNA isolation and real-time qRT-PCR 
quantiﬁcation 
After completion of the behavioral experiments, let-7d and 
D3R transcription levels were quantiﬁed using RT-PCR. In 
brief, the mice were killed by rapid decapitation, brains 
were quickly removed, and the entire hippocampal tissue 
was dissected out and frozen in liquid nitrogen then stored 
at − 80 °C. For more details, see the Supplementary Mate- 
rial . 
For the qPCR, 20 μL of ampliﬁcation mixture with SYBR- 
Green Kit was used containing 4 μL of cDNA and 100 nM 
primers as described in our previous studies. For more de- 
tails, see the Supplementary Material . 
2.5. Statistical analysis 
Statistical analysis was performed using SPSS version 16.0 
for Windows. All data are expressed as the mean ± SEM 
(Standard Error of Mean). For more details, see the Sup- 
plementary Material . 
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Fig. 2 Anxiety- and Depression-like behaviors like behavior in Mock- and let-7d-injected mice in the OF, EPM, TST and FST. For 
the OF test, the data are expressed as mean ± SEM for the (A) number of line crossings, (B) number of fecal boli, and (C) time 
spent in the center of the arena. For the EPM test, the data are expressed as mean ± SEM for the (D) percent of time spent in the 
open arms (OA), (E) number of entries into the OA, and F) number of entries into the closed arms (CA). For the TST, the data are 
expressed as mean ± SEM for the (G) latency, and (H) duration of immobility. For the FST, the data are expressed as mean ± SEM for 
the duration of (I) immobility, and (J) swimming. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.005. For both groups n = 12. 
3. Results 
The Levene’s test was used to inspect the equality of vari- 
ances of the groups compared and for all the analyses, the 
test was found to be statistically not signiﬁcant (For more 
details, see the Suppl Tables 1 and 2). 
3.1. Effects of let-7d overexpression on 
anxiety-like behavior in adult mice 
The open ﬁeld test (OF): this test was performed 10 days 
after the stereotaxic injections to investigate the effect of 
let-7d on anxiety-like behavior and spontaneous explorative 
locomotor activity. We evaluated mice performances in an 
OF test after injection of empty (Mock) or let-7d overex- 
pressing lentiviral vectors ( n = 12, each). For the average 
distance travelled, and as depicted in Fig. 2 A, the one-way 
ANOVA indicated that the number of line crossings did not 
differ signiﬁcantly between the two experimental groups 
(F (1,22 ) = 0.024, p = 0.879). However, let-7d overexpression 
produced an anxiolytic-like response as it signiﬁcantly de- 
creased the number of fecal boli (F (1,22 ) = 7.256, p = 0.013) 
( Fig. 2 B), and signiﬁcantly increased the time spent in the 
center of the arena during the OF test (F (1,22 ) = 16.053, 
p = 0.001) ( Fig. 2 C). 
The elevated plus maze test (EPM): we also estimated 
anxiety behaviors in Mock and let-7d-injected mice using 
the EPM test. Consistent with the above results, let-7d over- 
expressing mice showed more time spent in (F (1,22 ) = 10.486, 
p = 0.004) ( Fig. 2 D), and entering (F (1,22 ) = 7.688, p = 0.011) 
(Levene’s test: F (1,22 ) = 0.762, p = 0.392) ( Fig. 2 E) the open 
arms (OA) compared with the Mock controls. However, there 
were no statistically signiﬁcant differences between the 
groups in the number of entries into the closed arms (CA) 
(F (1,22 ) = 0.245, p = 0.626) ( Fig. 2 F). These data indicate 
that let-7d overexpression in the hippocampus may induce 
an anxiolytic-like response with no confounding locomotor 
activity changes. 
3.2. Effects of let-7d overexpression on 
depression-like behavior in adult mice 
The tail suspension test (TST): to determine whether in- 
creased hippocampal let-7d expression might be accom- 
panied by development of an anti-depressive phenotype, 
we tested Mock- and let-7d-injected mice in the TST. Be- 
havioral despair in this task is deﬁned as an increase 
in immobility in response to inescapable stress and mice 
were considered immobile when they hung motionless with 
their limbs tucked against their bodies. As depicted in 
Fig. 2 G and as compared with mice in the Mock con- 
trol group, mice injected with let-7d overexpressing vec- 
tors showed a signiﬁcant increase in their latency to im- 
mobility (F (1,22 ) = 9.033, p = 0.007). However, the duration 
of immobility was signiﬁcantly decreased following let-7d 
overexpression (F (1,22 ) = 10.702, p = 0.003) ( Fig. 2 H), sug- 
gesting that let-7d can reduce depression-like behavior in 
mice. 
The forced swim test (FST): the FST was conducted af- 
ter the TST, and the data analysis indicated that let-7d 
overexpression in the hippocampus signiﬁcantly decreased 
the immobility time (F (1,22 ) = 13.668, p = 0.001), as com- 
pared with the Mock control group ( Fig. 2 I). However, 
let-7d-overexpressing mice spent signiﬁcantly more time 
swimming (F (1,22 ) = 8.219, p = 0.009) ( Fig. 2 J), and climb- 
ing (F (1,22 ) = 5.172, p = 0.033) (data not shown) than their 
Mock controls, indicating that these mice have a signiﬁ- 
cantly decreased behavioral despair and conﬁrming the TST 
data, that hippocampal let-7d overexpression can reduce 
depression-like behavior in mice. 
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Fig. 3 Pearson’s correlations between let-7d expression and 
anxiety- and depression like behaviors. The data represent sim- 
ple scatter regression between let-7d levels with the (A) time 
spent in the center of the arena of the OF test, (B) number of 
entries into the OA, and (C) number of entries into the CA of the 
EPM test, (D) duration of immobility in the TST, and duration of 
(E) immobility, (F) swimming in the FST. 
3.3. The quantiﬁcation of let-7d and D3R levels 
using real-time qRT-PCR 
After completion of the behavioral experiments, the mice 
were killed by rapid decapitation, the brains were re- 
moved, the hippocampi were dissected out and let-7d lev- 
els were quantiﬁed using qRT-PCR. The quantiﬁcation re- 
vealed that when let-7d was injected into the hippocampus, 
transcript levels increased to approximately 225% compared 
to Mock controls (2.252 ± 0.164 and 1.000 ± 0.160 respec- 
tively). Thus, the one-way ANOVA analysis indicated that 
expression levels differed signiﬁcantly between the two ex- 
perimental groups (F (1,22 ) = 49.054, p < 0.0001). 
Using the data of let-7d transcription levels obtained 
from the Mock- and let-7d-injected mice, a simple linear re- 
gression (Pearson’s) analysis was performed to examine the 
correlation between let-7d transcription levels and parame- 
ters of anxiety- and depression-like behaviors and the scat- 
ter plots are provided in Fig. 3 . Post hoc linear regressions 
revealed that differences in let-7d levels within the hip- 
pocampus accounted for many of the behavioral alterations 
exhibited by the mice. In fact, in the OF test, increased let- 
7d expression was positively correlated with amount of time 
spent in the center of the arena (F (1,22 ) = 14.954, p = 0.001; 
Fig. 3 A). Similarly, in the EPM test, the Pearson’s correlation 
and Post-hoc corrections revealed that let-7d expression 
correlated positively with the number of entries into the OA 
(F (1,22 ) = 9.122, p = 0.006; Fig. 3 B), but not with the number 
of entries into the CA (F (1,22 ) = 1.638, p = 0.214; Fig. 3 C). 
The relations between let-7d expression levels and mea- 
sures of depression were also determined. In the TST, the 
results have shown a signiﬁcant negative correlation with 
immobility duration (F (1,22 ) = 7.665, p = 0.011; Fig. 3 D). Fi- 
Fig. 4 Pearson’s correlations between D3R mRNA expression 
and anxiety- and depression like behaviors. The data represent 
simple scatter regression between D3R levels with (A) let-7d 
expression. (B) time spent in the center of the arena of the OF 
test, (C) number of entries into the OA of the EPM test, (D) du- 
ration of immobility in the TST, and duration of (E) immobility, 
and (F) swimming in the FST. 
nally, in the FST, increased let-7d expression was negatively 
correlated with the latency to immobility (F (1,22 ) = 15.600, 
p = 0.001; Fig. 3 E) and positively correlated with swimming 
(F (1,22 ) = 13.811, p = 0.001; Fig. 3 F). For the rest of the cor- 
relations and scatter plots see Suppl. Fig. 1. 
We also quantiﬁed the mRNA levels of let-7d direct tar- 
get D3R, and the expression levels in Mock- and let-7d- 
injected mice were 1.000 ± 0.150 and 0.391 ± 0.155 respec- 
tively. Thus, the one-way ANOVA analysis revealed that let- 
7d overexpression resulted in an approximately 60% marked 
and signiﬁcant down-regulation of the D3R mRNA expression 
in the hippocampus (F (1,22 ) = 110.499, p < 0.0001). Most im- 
pressively, the Pearson’s analysis showed a signiﬁcant neg- 
ative correlation between let-7d and D3R expression levels 
(F (1,22 ) = 18.815, p < 0.0001; Fig. 4 A). 
Additionally, post hoc linear regressions revealed that al- 
terations in D3R mRNA expression accounted for many of 
the behavioral changes. In fact, in the OF test, D3R mRNA 
expression correlated negatively with the time spent in 
the center (F (1,22 ) = 14.248, p = 0.001; Fig. 4 B). Also, in the 
EPM test, D3R expression correlated negatively with the 
number of entries into the OA (F (1,22 ) = 14.759, p = 0.001; 
Fig. 4 C ). In the TST, results also indicated a positive cor- 
relation with immobility duration (F (1,22 ) = 8.564, p = 0.008; 
Fig. 4 D), and ﬁnally, in the FST, decreased D3R levels 
were positively correlated with the immobility duration 
(F (1,22 ) = 8.549, p = 0.008; Fig. 4 E) and negatively correlated 
with swimming duration (F (1,22 ) = 9.280, p = 0.006; Fig. 4 F). 
For the rest of the correlations and scatter plots see Suppl. 
Fig. 2. 
Taken together, these ﬁndings suggest that mice with high 
let-7d levels in the hippocampus are most likely to have low 
5
htt
p:/
/do
c.r
ero
.ch
Fig. 5 Anxiety- and depression like behaviors in Mock- and 
D3R-injected mice in the OF, EPM, TST and FST with access to 
water (WTR) or doxycycline (DOX). For the OF test, the data 
are expressed as mean ± SEM for the (A) time spent in the cen- 
ter of the arena. For the EPM test, the data are expressed as 
mean ± SEM for the (B) number of entries into the OA, and (C) 
number of entries into the CA. For the TST, the data are ex- 
pressed as mean ± SEM for the (D) duration of immobility. For 
the FST, the data are expressed as mean ± SEM for the duration 
of (E) immobility, and (F) swimming. ∗p < 0.05 indicate signiﬁ- 
cant differences between Mock and D3R; # p < 0.05 indicate sig- 
niﬁcant differences between WTR and DOX. For all the groups 
n = 10. 
D3R mRNA levels that are in turn associated with reduced 
anxiety- and depression-like phenotypes. 
3.4. Effects of D3R overexpression on 
anxiety-like behavior in adult mice 
The impact of D3R overexpression in the hippocampus on 
anxiety-like behavior was determined 10 and 12 days after 
the viral injection using the OF and the EPM tests respec- 
tively. 
The open ﬁeld test (OF): Fig. 5 A illustrates a 
signiﬁcantly lower time spent in the center of the 
arena in D3R-overexpressing mice than their Mock con- 
trols (F (1,36 ) = 4.218, p = 0.047), and the same anal- 
ysis revealed that doxycycline signiﬁcantly abrogated 
this difference (F (1,36 ) = 6.513, p = 0.015). Importantly, 
the viral-injection ×doxycycline was found signiﬁcant 
(F (1,36 ) = 10.164, p = 0.003). Although there was a signiﬁ- 
cant effect of viral-injection across both groups, post-hoc 
tests revealed that this effect was driven by the WTR group 
(WTR-Mock vs. WTR-D3R, p = 0.004; Bonferroni post-hoc 
test). In contrast, no signiﬁcant difference was found in the 
DOX group between Mock-and D3R-injected mice ( p = 1.000) 
and (WTR-D3R vs. DOX-D3R, p = 0.002; Bonferroni post-hoc 
test). 
The elevated plus maze test (EPM): the data from 
the EPM test showed that D3R-injected mice had a de- 
creased number of entries into the OA (main effect of 
viral-injection: F (1,36 ) = 5.832, p = 0.021), an effect that was 
signiﬁcantly abrogated when mice had access to doxycy- 
cline (F (1,36 ) = 5.832, p = 0.021) with signiﬁcant interaction 
(F (1,36 ) = 10.675, p = 0.002) ( Fig. 5 B). It should be mentioned 
that the D3R effects on the parameters measured in the EPM 
test were mainly driven by the WTR group, which differ- 
entially and signiﬁcantly affected the Mock- and D3R- in- 
jected groups ( p = 0.002, Bonferroni post hoc test). Like- 
wise, there was no signiﬁcant effect of D3R overexpression 
on the number of entries into the OA in presence of doxycy- 
cline ( p = 1.000 and WTR-D3R vs. DOX-D3R, p = 0.002; Bon- 
ferroni post hoc test). The overall activity was estimated 
by the number of entries performed into the CA during the 
5-min observation period. And the two-way ANOVA analysis 
indicated that this parameter was affected following D3R 
overexpression (F (1,36 ) = 1.282, p = 0.265). Likewise, there 
was no signiﬁcant effect of doxycycline on the number 
of entries into the CA (F (1,36 ) = 0.044, p = 0.835), nor was 
there a signiﬁcant viral-injection by doxycycline interaction 
(F (1,36 ) = 0.213, p = 0.647) ( Fig. 5 C) indicating no change in 
overall ambulatory behavior, and suggesting that hypothet- 
ical overly sedating effects of viral injection did not con- 
found the anxiety-like behavioral results reported above. 
Additional results are depicted in Suppl. Fig. 3. 
3.5. Effects of D3R overexpression on 
depression-like behavior in adult mice 
To investigate the effect of D3R overexpression on 
depression-like behavior, the TST the FST were performed. 
The tail suspension test (TST): as depicted in Fig. 5 D, 
although the effect of D3R overexpression on the dura- 
tion of immobility did not reach statistical signiﬁcance 
(F (1,36 ) = 3.607, p = 0.066), doxycycline blunted that ef- 
fect (F (1,36 ) = 4.825, p = 0.035) with a signiﬁcant interac- 
tion (F (1,36 ) = 4.871, p = 0.034). Again, the D3R effects were 
driven by the WTR group, which was signiﬁcantly different 
between the viral-injection conditions ( p = 0.038), whereas 
the doxycycline group did not differ between Mock- and 
D3R-injected rats ( p = 1.000 and WTR-D3R vs. DOX-D3R, 
p = 0.022; Bonferroni post hoc test). 
The forced swim test (FST): Fig. 5 E showed that 
the interaction between viral-injection and doxycy- 
cline had a signiﬁcant effect on the immobility du- 
ration (F (1,36 ) = 4.215, p = 0.047). The individual factors 
viral-injection (F (1,36 ) = 6.577, p = 0.015) and doxycycline 
(F (1,36 ) = 6.982, p = 0.012) also had signiﬁcant effects. The 
D3R overexpression-induced increase of immobility was sig- 
niﬁcant only in the WTR group but not in the DOXY group 
( p = 0.014 and p = 1.000 respectively) and (WTR-D3R vs. 
DOX-D3R, p = 0.012; Bonferroni post hoc test). For the 
swimming duration and as depicted in Fig. 5 F, both viral- 
injection (F (1,36 ) = 6.993, p = 0.012), and doxycycline treat- 
ment (F (1,36 ) = 7.988, p = 0.008) had signiﬁcant effects, with 
signiﬁcant interaction (F (1,36 ) = 5.516, p = 0.024). The ef- 
fects on swimming during this test were mainly driven by the 
WTR group, which differentially and signiﬁcantly affected 
the Mock- and D3R- injected groups ( p = 0.007). However, 
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there was no signiﬁcant effect of D3R overexpression on 
swimming in presence of doxycycline ( p = 1.000) and (WTR- 
D3R vs. DOX-D3R, p = 0.005; Bonferroni post hoc test). This 
ﬁnding indicated that doxycycline could prevent the de- 
crease of swimming behavior following D3R overexpression. 
Additional results are depicted in Suppl. Fig. 4. 
3.6. Quantiﬁcation of D3R levels using real-time 
qRT-PCR 
To investigate whether D3R overexpression and doxycycline 
altered the contents of D3R mRNA in the hippocampus, 
qRT-PCR was used. In the absence of doxycycline, D3R- 
injected mice exhibited a signiﬁcant increase in mRNA lev- 
els over Mock controls (1.000 ± 0.144 and 1.693 ± 0.145 
respectively). However, when doxycycline was given in 
drinking water, D3R mRNA quantiﬁcation revealed no sig- 
niﬁcant difference between Mock- and D3R experimen- 
tal groups (1.000 ± 0.181 and 1.138 ± 0.129 respectively). 
The two-way ANOVA analysis revealed main effect of 
viral-injection (F (1,36 ) = 57.716, p < 0.0001), and doxycy- 
cline (F (1,36 ) = 12.265, p = 0.001), with a signiﬁcant interac- 
tion between the two factors (F (1,36 ) = 15.066, p < 0.001). 
Post hoc evaluations indicated that in the WTR group, 
D3R overexpression increased D3R mRNA levels by approx- 
imately 170% (WTR-Mock vs. WTR-D3R, p < 0.0001). How- 
ever, when mice had access to doxycycline in the drinking 
water, no signiﬁcant difference was found between the two 
experimental groups (DOX-Mock vs. DOX-D3R, p = 0.075 and 
WTR-D3R vs. DOX-D3R, p < 0.001). 
Using the data of D3R mRNA levels obtained from the 
four experimental groups, we performed a Pearson’s lin- 
ear regression analysis to examine the correlation between 
D3R mRNA levels and anxiety- and depression-like behav- 
iors. The scatter plots are provided in Fig. 6 . Post hoc linear 
regressions revealed that differences in D3R levels were as- 
sociated with changes of behavior. In the OF test, D3R cor- 
related negatively with the time spent in the center of the 
arena (F (1,38 ) = 10.185, p = 0.003; Fig. 6 A). In the EPM test, 
D3R expression correlated negatively with the number of 
entries into the OA (F (1,38 ) = 13.060, p = 0.001; Fig. 6 B), but 
not with the number of entries into the CA (F (1,38 ) = 2.322, 
p = 0.136; Fig. 6 C). In the TST, results also indicated a pos- 
itive correlation with immobility duration (F (1,38 ) = 18.738, 
p < 0.001; Fig. 6 D). Finally, in the FST, decreased D3R lev- 
els were positively correlated with the latency to immobil- 
ity (F (1,38 ) = 10.756, p = 0.002; Fig. 6 H) and negatively cor- 
related with swimming duration (F (1,38 ) = 12.671, p = 0.001; 
Fig. 6 F). For the rest of the correlations and scatter plots 
see Suppl. Fig. 5. 
Taken together, these ﬁndings suggest that high D3R 
mRNA levels in the hippocampus are most likely to be as- 
sociated with increased anxiety- and depression-like pheno- 
types. 
4. Discussion 
The results of the present series of experiments show, for 
the ﬁrst time, that adult mice overexpressing let-7d in the 
hippocampus display a behavioral proﬁle that is consistent 
Fig. 6 Pearson’s correlations between D3R mRNA expression 
in Mock- and D3R-injected mice and anxiety- and depression 
like behaviors. The data represent simple scatter regression 
between D3R levels with (A) time spent in the center of the 
arena of the OF test, (B) number of entries into the OA, and (C) 
number of entries into the CA of the EPM test, (D) duration of 
immobility in the TST, and duration of (E) immobility, and (F) 
swimming in the FST. 
with an anxiolytic- and antidepressant-like action. Interest- 
ingly, the observed behavioral phenotype was associated to 
decreased D3R mRNA expression. In contrast, D3R overex- 
pression increased anxiety- and depression-like behaviors 
as measured in a battery of behavioral tests. The absence 
of signiﬁcant modiﬁcations in the numbers of line crossings 
and the number of CA entries (reliable measures of locomo- 
tor activity in the OF and EPM tests respectively) indicates 
that the anxiolytic-like activity, observed following let-7d 
and D3R overexpression in the hippocampus, did not impair 
spontaneous locomotor activity. These results indicate that 
let-7d is a critical regulator for D3R expresssion in mouse 
hippocampus and we hypothesize consequently that let-7d 
might participate in the neuropathophysiology of mood dis- 
orders through the regulation of D3R genetic expression. 
Our initial characterization of the behavioral effects of 
the functional manipulation of let-7d in the hippocampus 
showed that let-7d-overexpressing mice display a reduction 
in their level of anxiety, as evidenced by the increase in 
time spent in the center of the OF and the increased time 
spent in the OA of the EPM test. Closer examination sug- 
gests that these results were not associated with increased 
motor activity of these mice, as there was no signiﬁcant in- 
crease in the number of line crossings in the OF test, or in 
the amount of time spent in the CA of the plus maze. Also, 
let-7d overexpression decreased the immobility time in both 
the TST and FST suggesting that it is reasonable to believe 
that let-7d may play a crucial role in the development of 
anti-depressant-like behaviors in mice. A substantial liter- 
ature is emerging supporting miRNAs as differentially ex- 
pressed in affective disorders. In fact, Mendes-Silva and 
colleagues conducted a systematic review and found that 
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30 miRNAs microRNAs were abnormally expressed in MDD 
( Mendes-Silva et al., 2016 ). There is strong evidence that 
peripheral miRNAs may contribute to the pathophysiology of 
MDD and antidepressant response. In fact, genetic variants 
in the promoters of let-7 family have been associated with 
an increased risk of MDD ( Liang et al., 2015 ). Also, results 
indicated that, compared to control subjects, let-7d-3p are 
signiﬁcantly higher in the serum from the MDD patients com- 
pared to healthy controls. The up-regulation of let-7d-3p 
has been further conﬁrmed in different cohorts of 32 MDD 
patients ( Wan et al., 2015 ). In addition, it was reported that 
let-7d-5p expression was altered in MDD patients, and that 
the bioinformatic prediction of the targeted genes revealed 
the possible involvement of neural pathways relevant for 
psychiatric disorders ( Mafﬁoletti et al., 2016 ). Interestingly, 
Wei and colleagues reported downregulation of let-7 miRNA 
expression in the prefrontal cortex of a genetic rat model 
of depression, the Flinders Sensitive Line compared to the 
control Flinders Resistant Line ( Wei et al., 2016 ). Taken to- 
gether, these results emphasized the potential role of miR- 
NAs as physiological biomarkers among clinically depressed 
patients. However, procedural discrepancies in technology 
used to measure miRNA expression levels, structural dif- 
ferences in miRNA sequences, changes in the severity and 
forms of depression between patients, and the overall rarity 
of studies make it difﬁcult to establish any strong, prelim- 
inary targets as biomarker potential. Therefore, the ongo- 
ing and future studies need to address these methodological 
and reporting discrepancies in the miRNA research for more 
consistent candidates associated with MDD. The overexpres- 
sion of other miRNAs such as miR-17-92, miR-34b also de- 
creased anxiety-like behavior in mice and rats respectively 
( Jin et al., 2016; Zhu et al., 2017 ). However, miR-101a- 
3p-overexpressing adeno-associated viruses (AAVs) in the 
amygdala increased anxiety-like behavior in the OF and EPM 
tests of high-novelty-responding (HR) rats ( Cohen et al., 
2017 ). Also, miR-155 KO mice exhibited reduced ﬂoat du- 
ration and increased latency to ﬂoat ( Fonken et al., 2016 ), 
but, no changes in anxiety-like behavior were observed in 
miR-132/212 KO mice ( Hernandez-Rapp et al., 2015 ). Differ- 
ences between all these miRNAs’ sequences, target genes, 
as well as differences between species (rats vs. mice) are 
likely to contribute to these discrepancies. Furthermore, 
procedural differences (transgenics vs. viral vectors) may 
also contribute to these contrasting results. 
In an attempt to address one of the mechanisms by which 
let-7d might decrease anxiety- and depression-like behav- 
iors, we assessed the expression of the D3R in the hippocam- 
pus following let-7d overexpression. This target was chosen 
because previous studies from our laboratory indicated that 
let-7d manipulation in the nucleus accumbens altered D3R 
expression levels ( Chandrasekar and Dreyer, 2009 ). Results 
have shown that reduced D3R levels were associated with 
an increase of let-7d expression. To the best of our knowl- 
edge, we are the ﬁrst who could demonstrate a negative 
correlation between levels of D3R and the expression of let- 
7d in the hippocampus. Consequently, we tested the impact 
of D3R overexpression, using viral vectors, on anxiety- and 
depression-like behaviors with the hypothesis that, com- 
pared to let-7, D3R overexpression would have the oppo- 
site effects. As anticipated, the results indicated that D3R- 
overexpressing mice displayed robust effects predictive of 
anxiogenic and pro-depressant efﬁcacy without signiﬁcant 
effects on locomotor activity, suggesting that targeting the 
D3R may represent a novel therapeutic avenue for the treat- 
ment of some affective disorders. 
The potential implication of the D3R in the effects of 
antidepressants, such as imipramine, amitriptyline, citalo- 
pram and mianserin, was suggested by several reports in- 
dicating that when administered repeatedly, such drugs 
enhance the responsiveness of D3R, probably via an in- 
crease in the density and/or binding of these receptors 
( Lammers et al., 2000; Maj et al., 1998 ). In addition, the 
D3R is a clinically relevant therapeutic target for anxiety- 
and depression-related behaviors as clinically-used D3R- 
preferring agonists, aripiprazole, pramipexole, cariprazine, 
and ropinirole, have all been shown to have anxiolytic 
and/or antidepressant effects in humans and animal models 
( Duric et al., 2017; Rogers et al., 2000; Rogoz et al., 2004; 
Zarate et al., 2004 ). However, studies using D3R transgenic 
mice yielded conﬂicting results. For instance, D3R KO mice 
entered the center and the OA signiﬁcantly more than WT 
littermates in the OF and EPM tests respectively, but did not 
differ in CA entries, an index of general spontaneous loco- 
motor activity, with heterozygous mice showing intermedi- 
ate behavioral changes, suggesting reduced anxiety in mice 
lacking the D3R ( Steiner et al., 1997 ). However, Chourbaji 
and co-workers reported D3R KO mice to have regular emo- 
tional behavior in a series of selected behavioral paradigms 
focusing on depressive-like traits ( Chourbaji et al., 2008 ). 
In contrast, a more recent study revealed that D3R deﬁ- 
ciency resulted in anxiety- and depressive-like symptoms 
that cannot be attributed to motor dysfunction ( Moraga- 
Amaro et al., 2014 ). To circumvent these discrepancies, we 
strongly believe that, compared to genetically engineered 
transgenic mice, viral vectors’ technology is a relatively 
rapid and reliable method for in vivo assessment of the D3R 
in the brain. In addition, the up regulation of D3R, using 
lentivirus injection in our case, happens at a speciﬁc time 
in the adult mouse (temporal control) and does not include 
any possibility of leakiness or functional compensation dur- 
ing development, as is most often the case in transgenic 
mice. Moreover, lentivirus injection provides precise spatial 
control which, again, is subject to a certain amount of leak- 
iness in the transgenic systems. 
Our observations showed that ectopic D3R enhanced the 
immobility duration in mice in the TST and reduced swim- 
ming in the FST. This may suggest that hippocampal D3R 
overexpression induces a certain neurochemical abnormal- 
ity which causes the mice to remain immobile in the TST 
and enter in a state of despair in the FST. Nevertheless, 
these tests, and particularly the FST, have some disadvan- 
tages, such as their unpredictability in uncovering of the 
effects of a broad spectrum of drugs. In fact, the selective 
serotonin reuptake inhibitors, a major group of antidepres- 
sant drugs, prevent the development of behavioral immo- 
bility in the FST ( Borsini and Meli, 1988 ). However, a signiﬁ- 
cant adjustment of the traditional FST procedure conﬁrmed 
that speciﬁc behavioral components of active behaviors in 
the FST distinguished neurochemically different antidepres- 
sant drugs ( Lucki, 1997 ). Indeed, the modiﬁed procedure 
indicated that enhancement of catecholamine neurotrans- 
mission may facilitate climbing, whereas enhancement of 
serotoninergic neurotransmission may mediate swimming. 
8
htt
p:/
/do
c.r
ero
.ch
( Detke et al., 1995; Lucki, 1997 ). Regardless, the manifes- 
tation of these psychiatric disorders required functional D3R 
because among dopamine receptor subtypes, the D3R has 
the highest afﬁnity for dopamine ( Sokoloff et al., 1992 ). One 
possible explanation is that at least in the hippocampus, 
permanent D3R overexpression/activation, which might in- 
crease receptors’ availability, could lead to development 
of anxiety- and depression-related disorders. Indeed, it is 
very well established that, in rats, the administration of 
dopaminergic drugs such as methylphenidate (e.g. Rital- 
in®), during pre- and periadolescent development, resulted 
in the development of psychiatric disorders in adulthood 
( Bolanos et al., 2003 ). These results demonstrate the poten- 
tial dopamine-dependent nature of anxiety- and depression- 
like behaviors in rodents and show the possible implication 
of the D3R. These ﬁndings also highlight the need for further 
research to improve understanding the therapeutic poten- 
tial of D3R for anxiety, depression, and other related mood 
disorders. 
In conclusion, lentiviral-mediated let-7d overexpression 
in the hippocampus of adult mice decreases their anxiety- 
and depression-like behaviors and reduces D3R mRNA levels. 
However, direct D3R overexpression results in the opposite 
effects. Thus, we hypothesize that increasing the expression 
of let-7d in the hippocampus produces an anxiolytic- and 
antidepressant-like effect that is at least partially medi- 
ated via the repression of the D3R expression. Overall, these 
studies point to a novel molecular mechanism that may con- 
tribute to individual differences in certain mood disorders. 
They also add to the growing literature supporting a role 
for mechanisms once considered to be exclusive to devel- 
opment and differentiation, such as miRNA and epigenetic 
regulation, in the adult brain and in underlying behavioral 
phenomena related to psychiatric disorders. 
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